Neuraltus Pharmaceuticals, Inc. Product Pipeline Review 2012: ResearchMoz include new market research report"Neuraltus Pharmaceuticals, Inc. Product Pipeline Review 2012" to its huge collection of research reports.


Albany, NY -- (SBWIRE) -- 01/14/2013 -- Global Market Directs pharmaceuticals report, Neuraltus Pharmaceuticals, Inc. - Product Pipeline Review - 2012 provides data on the Neuraltus Pharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Directs proprietary databases, Neuraltus Pharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Neuraltus Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Directs team.


- Neuraltus Pharmaceuticals, Inc. - Brief Neuraltus Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Neuraltus Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Neuraltus Pharmaceuticals, Inc. with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Neuraltus Pharmaceuticals, Inc.s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Neuraltus Pharmaceuticals, Inc.s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Neuraltus Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Neuraltus Pharmaceuticals, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Neuraltus Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Neuraltus Pharmaceuticals, Inc. and identify potential opportunities in those areas.

To know more about this reports, please visit @

Contact: for further information.